NASDAQ:OCUP
Ocuphire Pharma, Inc.
- Stock
Last Close
2.04
26/07 20:00
Market Cap
42.77M
Beta: −0.03
Volume Today
51.73K
Avg: 270.07K
PE Ratio
1.85
PFCF: 2.61
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
revenue | 589K - | 39.85M 6,665.70% | 19.05M 52.20% | |||||||||
cost of revenue | 3K - | 8K 166.67% | 4K 50% | 4K 0% | 6K 50% | |||||||
gross profit | -3K - | -8K 166.67% | 585K 7,412.50% | 39.85M 6,711.28% | 19.04M 52.21% | |||||||
selling and marketing expenses | -6K - | |||||||||||
general and administrative expenses | 4.26M - | 6.25M 46.78% | 6.12M 2.21% | 6.32M 3.42% | 6.64M 4.98% | 7.43M 11.89% | 1.82M 75.50% | 2.82M 54.84% | 8.12M 188.18% | 7.27M 10.49% | 11.96M 64.52% | |
selling general and administrative expenses | 4.26M - | 6.25M 46.78% | 6.12M 2.21% | 6.32M 3.42% | 6.64M 4.98% | 7.43M 11.89% | 1.82M 75.50% | 2.82M 54.84% | 8.12M 188.18% | 7.27M 10.49% | 11.95M 64.44% | |
research and development expenses | 3.25M - | 7.02M 115.67% | 12.15M 73.15% | 10.09M 16.95% | 10.72M 6.21% | 13.11M 22.34% | 2.37M 81.90% | 6.65M 180.15% | 15.17M 128.23% | 14.36M 5.39% | 17.65M 22.97% | |
other expenses | -68K - | 9K 113.24% | -157K 1,844.44% | -14K 91.08% | 1.84M 13,221.43% | |||||||
cost and expenses | 7.51M - | 13.27M 76.61% | 18.26M 37.64% | 16.41M 10.13% | 17.35M 5.74% | 20.54M 18.34% | 4.19M 79.58% | 9.47M 125.76% | 23.29M 146.08% | 21.62M 7.17% | 29.61M 36.94% | |
operating expenses | 7.51M - | 13.27M 76.61% | 18.26M 37.64% | 16.41M 10.13% | 17.35M 5.74% | 20.54M 18.34% | 4.19M 79.58% | 9.47M 125.76% | 23.29M 146.08% | 21.62M 7.17% | 29.61M 36.91% | |
interest expense | 1.41M - | 6.85M 385.95% | 2K 99.97% | 9K 350% | ||||||||
ebitda | -7.94M - | -13.27M 67.08% | -18.26M 37.64% | -16.41M 10.13% | -17.35M 5.74% | -20.54M 18.34% | -4.26M 79.27% | -9.45M 121.91% | -22.86M 141.95% | 18.21M 179.66% | -10.56M 157.97% | |
operating income | -7.98M - | -13.27M 66.31% | -18.26M 37.64% | -16.41M 10.13% | -17.35M 5.74% | -20.54M 18.34% | -4.19M 79.58% | -19.97M 376.22% | -22.70M 13.71% | 18.23M 180.27% | -10.56M 157.96% | |
depreciation and amortization | 37.13K - | -65K - | 10.52M 16,283.08% | -157K 101.49% | -14K 91.08% | 6K 142.86% | ||||||
total other income expenses net | -1.52M - | -5.25M 245.42% | 3.88M 173.85% | 7.11M 83.20% | -7.94M 211.73% | 6.17M 177.70% | -1.98M 132.03% | -4.65M 135.43% | -33.99M 630.61% | -23K 99.93% | 589K 2,660.87% | |
income before tax | -9.50M - | -18.52M 94.98% | -14.38M 22.34% | -9.31M 35.30% | -25.29M 171.77% | -14.37M 43.20% | -6.17M 57.07% | -24.62M 299.09% | -56.69M 130.27% | 18.20M 132.11% | -9.97M 154.79% | |
income tax expense | 1.34M - | 6.86M 411.26% | -159K 102.32% | 315K 298.11% | 12K 96.19% | |||||||
net income | -9.50M - | -18.52M 94.98% | -14.38M 22.34% | -9.31M 35.30% | -25.29M 171.77% | -14.37M 43.20% | -7.51M 47.73% | -31.48M 319.12% | -56.53M 79.61% | 17.89M 131.64% | -9.99M 155.83% | |
weighted average shs out | 128.65M - | 176.11M 36.89% | 182.39M 3.57% | 217.45M 19.22% | 27.39M 87.40% | 32.92M 20.17% | 711.21K 97.84% | 4.66M 555.38% | 14.85M 218.65% | 19.93M 34.19% | 21.59M 8.32% | |
weighted average shs out dil | 128.65M - | 176.11M 36.89% | 182.39M 3.57% | 217.45M 19.22% | 27.39M 87.40% | 32.92M 20.17% | 711.21K 97.84% | 4.66M 555.38% | 14.85M 218.65% | 20.60M 38.68% | 21.59M 4.82% | |
eps | -0.07 - | -0.11 49.05% | -0.08 28.27% | -0.04 45.75% | -0.92 2,049.53% | -0.44 52.17% | -10.56 2,300.00% | -6.75 36.08% | -3.81 43.56% | 0.90 123.62% | -0.46 151.11% | |
epsdiluted | -0.07 - | -0.11 49.05% | -0.08 28.27% | -0.04 45.75% | -0.92 2,049.53% | -0.44 52.17% | -10.56 2,300.00% | -6.75 36.08% | -3.81 43.56% | 0.87 122.83% | -0.46 152.87% |
All numbers in USD (except ratios and percentages)